Literature DB >> 15784031

Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic Fatty liver disease.

Zeki Yesilova1, Halil Yaman, Cagatay Oktenli, Ayhan Ozcan, Ahmet Uygun, Erdinc Cakir, S Yavuz Sanisoglu, Ahmet Erdil, Yüksel Ates, Murat Aslan, Ugur Musabak, M Kemal Erbil, Necmettin Karaeren, Kemal Dagalp.   

Abstract

OBJECTIVES: The aim of the present study was to examine the systemic parameters of oxidative stress and antioxidants in patients with nonalcoholic fatty liver disease and investigate the relationship between these parameters and clinical and biochemical outcomes.
METHODS: Fifty-one male patients with nonalcoholic fatty liver disease (group I), 30 age-matched and body mass index (BMI)-matched healthy male subjects, and 30 age-matched male patients with chronic viral hepatitis (group II) were enrolled in the study.
RESULTS: Increased systemic levels of malondialdehyde and depletion of antioxidants such as coenzyme Q10, CuZn-superoxide dismutase, and catalase activity were observed in group I. Coenzyme Q10 and CuZn-superoxide dismutase correlated negatively with increasing necroinflammatory activity and fibrosis. Body fat was negatively associated with plasma coenzyme Q10 levels, while an inverse association was found between plasma catalase levels and TG. However, LDL was positively associated with plasma malondialdehyde levels. CuZn-superoxide dismutase levels were negatively associated with glucose, insulin, and HOMA-IR. In addition, the levels of CuZn-superoxide dismutase correlated significantly in a negative manner with BMI.
CONCLUSIONS: Our results concerning correlations suggest that disturbances in BMI, body fat, and lipid metabolism may contribute to altered oxidative status in NAFLD, and insulin resistance may be related to decreased antioxidants in NAFLD as well as products of lipid peroxidation. However, although our results suggest interesting correlations, this different mostly "weak" relationships must be taken with caution.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15784031     DOI: 10.1111/j.1572-0241.2005.41500.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  79 in total

Review 1.  Noninvasive biomarkers in non-alcoholic fatty liver disease: current status and a glimpse of the future.

Authors:  Emer Fitzpatrick; Anil Dhawan
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

2.  Oxidized metabolites of linoleic acid as biomarkers of liver injury in nonalcoholic steatohepatitis.

Authors:  Nicola Santoro; Sonia Caprio; Ariel E Feldstein
Journal:  Clin Lipidol       Date:  2013-08-01

Review 3.  Inflammation and fibrogenesis in steatohepatitis.

Authors:  Hideki Fujii; Norifumi Kawada
Journal:  J Gastroenterol       Date:  2012-02-07       Impact factor: 7.527

4.  The intertwisted correlations among non-alcoholic fatty liver disease, atherosclerosis, and metabolic syndrome.

Authors:  Haruhisa Nakao; Masashi Yoneda
Journal:  J Gastroenterol       Date:  2009       Impact factor: 7.527

Review 5.  Modern approach to the clinical management of non-alcoholic fatty liver disease.

Authors:  Maria Del Ben; Licia Polimeni; Francesco Baratta; Daniele Pastori; Lorenzo Loffredo; Francesco Angelico
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

Review 6.  The Effects of Physical Exercise on Fatty Liver Disease.

Authors:  Dirk J van der Windt; Vikas Sud; Hongji Zhang; Allan Tsung; Hai Huang
Journal:  Gene Expr       Date:  2017-12-06

7.  Influence of different concentrations of uric acid on oxidative stress in steatosis hepatocytes.

Authors:  Shi Cheng; Yan Yang; Yong Zhou; Wei Xiang; Hua Yao; Ling Ma
Journal:  Exp Ther Med       Date:  2018-02-12       Impact factor: 2.447

Review 8.  Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease.

Authors:  Harmeet Malhi; Gregory J Gores
Journal:  Semin Liver Dis       Date:  2008-10-27       Impact factor: 6.115

9.  4-HNE Immunohistochemistry and Image Analysis for Detection of Lipid Peroxidation in Human Liver Samples Using Vitamin E Treatment in NAFLD as a Proof of Concept.

Authors:  Maren C Podszun; Joon-Yong Chung; Kris Ylaya; David E Kleiner; Stephen M Hewitt; Yaron Rotman
Journal:  J Histochem Cytochem       Date:  2020-09       Impact factor: 2.479

Review 10.  Pathogenesis of non-alcoholic fatty liver disease.

Authors:  J K Dowman; J W Tomlinson; P N Newsome
Journal:  QJM       Date:  2009-11-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.